Cargando…

Epidemiology of Infections in Cancer Patients

Although major advances in the care of cancer patients over the past several decades have resulted in improved survival, infectious complications remain a significant cause of morbidity and mortality. To successfully identify, treat, and prevent infections, a comprehensive understanding of risk fact...

Descripción completa

Detalles Bibliográficos
Autor principal: Zembower, Teresa R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120867/
https://www.ncbi.nlm.nih.gov/pubmed/24706221
http://dx.doi.org/10.1007/978-3-319-04220-6_2
_version_ 1783515072253919232
author Zembower, Teresa R.
author_facet Zembower, Teresa R.
author_sort Zembower, Teresa R.
collection PubMed
description Although major advances in the care of cancer patients over the past several decades have resulted in improved survival, infectious complications remain a significant cause of morbidity and mortality. To successfully identify, treat, and prevent infections, a comprehensive understanding of risk factors that predispose to infection and of commonly encountered pathogens is necessary. In addition, clinicians must keep abreast of the changing epidemiology of infections in this population. As therapeutic modalities continue to evolve, as established pathogens become increasingly drug resistant, and as new pathogens are discovered, successful management of infections will continue to present challenges in the years to come.
format Online
Article
Text
id pubmed-7120867
institution National Center for Biotechnology Information
language English
publishDate 2014
record_format MEDLINE/PubMed
spelling pubmed-71208672020-04-06 Epidemiology of Infections in Cancer Patients Zembower, Teresa R. Infectious Complications in Cancer Patients Article Although major advances in the care of cancer patients over the past several decades have resulted in improved survival, infectious complications remain a significant cause of morbidity and mortality. To successfully identify, treat, and prevent infections, a comprehensive understanding of risk factors that predispose to infection and of commonly encountered pathogens is necessary. In addition, clinicians must keep abreast of the changing epidemiology of infections in this population. As therapeutic modalities continue to evolve, as established pathogens become increasingly drug resistant, and as new pathogens are discovered, successful management of infections will continue to present challenges in the years to come. 2014-04-06 /pmc/articles/PMC7120867/ /pubmed/24706221 http://dx.doi.org/10.1007/978-3-319-04220-6_2 Text en © Springer International Publishing Switzerland 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Article
Zembower, Teresa R.
Epidemiology of Infections in Cancer Patients
title Epidemiology of Infections in Cancer Patients
title_full Epidemiology of Infections in Cancer Patients
title_fullStr Epidemiology of Infections in Cancer Patients
title_full_unstemmed Epidemiology of Infections in Cancer Patients
title_short Epidemiology of Infections in Cancer Patients
title_sort epidemiology of infections in cancer patients
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7120867/
https://www.ncbi.nlm.nih.gov/pubmed/24706221
http://dx.doi.org/10.1007/978-3-319-04220-6_2
work_keys_str_mv AT zembowerteresar epidemiologyofinfectionsincancerpatients